Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3. This indicates a minor maintenance update with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-04T03:52:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects a site release update rather than modifications to the study content.
    Difference
    0.0%
    Check dated 2026-06-26T23:57:47.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment label (Intervention/Treatment added vs Intervention / Treatment removed) and updates the revision tag from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T16:38:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Version label on the page changed from v3.5.4 to v3.5.5, indicating a new page release. The study content remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-05T12:06:43.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, representing a minor update to the page metadata. There is no indication of changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-05-15T05:42:59.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Taiwan location entry updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. This clarifies the city designation in the study's locations list while keeping the same postal code, ensuring accurate site identification for potential participants.
    Difference
    0.0%
    Check dated 2026-05-08T05:27:11.000Z thumbnail image

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.